Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

102.400
+1.2001.19%
Volume:15.25M
Turnover:1.56B
Market Cap:178.59B
PE:186.71
High:104.000
Open:101.800
Low:100.600
Close:101.200
52wk High:109.100
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:1.10
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:5.01%
ROA:1.56%
PB:7.91
PE(LYR):186.71
PS:11.74

Loading ...

Movement Alert|INNOVENT BIO Rises 5.77% in Regular Trading, H1 Product Revenue Exceeds RMB 8.2 Billion with 55%+ YoY Growth

Market Focus
·
Aug 05

Hong Kong Listed Companies' News Digest: Innovent Bio's First-Half Product Revenue Exceeds RMB 8.2 Billion, Up Over 55% Year-on-Year

Stock News
·
Aug 05

Innovent Biologics Says First Half 2026 Product Revenue Exceeds Rmb8.2 Billion

Reuters
·
Aug 05

Innovent reports H1 2026 product revenue surpassing RMB 8.20 billion, up more than 55%; Q2 alone tops RMB 4.30 billion with 60% growth

Bulletin Express
·
Aug 05

Innovent Biologics - First Half 2026 Product Revenue Exceeds Rmb8.2 Bln, up over 55% Y/Y

THOMSON REUTERS
·
Aug 05

Movement Alert|INNOVENT BIO Declines 3.52% in Regular Trading, Trading at 83.5 HKD

Market Focus
·
Aug 03

Medtide Names Ding Lijun as CFO

Reuters
·
Jul 31

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Movement Alert|INNOVENT BIO Declines 3.12% in Regular Trading, Trading at 86.8 HKD

Market Focus
·
Jul 30

Obesity Specialty Standardized Weight Management Service System Initiative Launches in China

Deep News
·
Jul 26

Movement Alert|Innovent Biologics Rises 3.04% in Regular Trading, BD Deal Catalyst and Biotech Sector Recovery Drive Gains

Market Focus
·
Jul 20

Movement Alert|Innovent Biologics Falls 3.45% in Regular Trading, Trading at HK$89.85

Market Focus
·
Jul 17

Innovent Biologics (SEHK:1801) Is Up 9.1% After Striking US$1.10 Billion IBI355 Licensing Deal

Simply Wall St.
·
Jul 16

CLSA Raises Innovent Biologics Price Target to HK$139.9, Citing New Overseas Partnership

Stock News
·
Jul 16

Movement Alert|Innovent Biologics Falls 3.09% in Regular Trading, Trading at 94.4 HKD

Market Focus
·
Jul 16

Hong Kong Market Analysis: Longxun's IPO Valuation Sets Benchmark, Stirring Tech Sector; "Lab Monkey" Prices Drive CXO Surge

Stock News
·
Jul 15

Hong Kong Market Rises 1.4% on Fed Policy Shift Hopes; Healthcare and Consumer Stocks Lead Gains

Stock News
·
Jul 15

Innovent Biologics Shares Surge on Spero Deal That Could be Worth $1.1 Bln

Dow Jones
·
Jul 15

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Stock News
·
Jul 15

Innovent Biologics Shares Rise Over 3% on Exclusive Licensing Deal for IBI355 and Upcoming SjD Phase II Study

Stock News
·
Jul 15